Literature DB >> 849084

Metastatic pulmonary calcification in primary hyperparathyroidism.

A M Cohen, H R Maxon, R E Goldsmith, H J Schneider, J F Wiot, R G Loudon, W A Altemeier.   

Abstract

Metastic pulmonary calcification (MPC) developed in a patient with primary hyperparathyroidism. Renal function was only minimally impaired (creatine clearance of 65 ml/min) the day prior to appearance of the lung infiltrate, but deteriorated (creatinine clearance of 14 ml/min) concomitantly with the appearance of MPC. Lung imaging with 99mTc bone-scanning agents helps differentiate MPC from other problems with similar clinical and roentgenographic findings, thus allowing prompt therapy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 849084

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  Bone scanning in patients with pleural effusion--experience in 76 cases.

Authors:  S Kosuda; K Yokoyama; I Nishiguchi; E Kunieda; A Kubo; S Hashimoto
Journal:  Ann Nucl Med       Date:  1990-07       Impact factor: 2.668

2.  Metastatic calcifications and severe hypercalcemia in a patient with parathyroid carcinoma.

Authors:  P Valdivielso; J López-Sánchez; A Garrido; J J Sánchez-Carrillo
Journal:  J Endocrinol Invest       Date:  2006 Jul-Aug       Impact factor: 4.256

Review 3.  Rapid development of metastatic pulmonary calcifications in primary hyperparathyroidism: a case report and literature review.

Authors:  Hui-Ming Sun; Fei Chen; Hong-Lin Yin; Xiao-Yong Xu; Hong-Bing Liu; Bei-Lei Zhao
Journal:  Diagn Pathol       Date:  2017-05-08       Impact factor: 2.644

4.  A rare case of parathyroid crisis with respiratory failure successfully treated using extracorporeal membrane oxygenation.

Authors:  Shunkichi Ikegaki; Takehiro Otoshi; Tomoyuki Hirai; Masataka Hirabayashi
Journal:  Respir Med Case Rep       Date:  2020-05-11

5.  Primary hyperparathyroidism characterized by diffuse homogeneous metastatic pulmonary calcification: A case report.

Authors:  Yuzhu Jia; Lihua Wang; Guangzhao Yang; Guoqun Mao; Yougen Cheng; Yulin Cao
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.